World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
110
Citations
54167
World Ranking
5475
National Ranking
2949

John Varga publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where John Varga sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 467 publications — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

John Varga D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where John Varga sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 110 D-Index — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

John Varga is affiliated with the University of Michigan-Ann Arbor in the United States. Their research primarily focuses on multiple areas within medicine, with a strong emphasis on systemic sclerosis and related diseases.

The main fields of study for John Varga encompass medicine, including several specialized subfields such as pathology and forensic medicine, pulmonary and respiratory medicine, epidemiology, dermatology, and immunology. Their work covers a range of key topics, including systemic sclerosis and related diseases, interstitial lung diseases and idiopathic pulmonary fibrosis, inflammatory myopathies and dermatomyositis, dermatologic treatments and research, mast cells and histamine, eosinophilic disorders and syndromes, and body image and dysmorphia studies.

The scientist has collaborated frequently with several coauthors, including:

  • Dinesh Khanna
  • Swati Bhattacharyya
  • Pei-Suen Tsou
  • Swarna Bale
  • Monique Hinchcliff

John Varga has published extensively in a number of scientific journals. Their frequent publication venues are:

  • Journal of Investigative Dermatology
  • JCI Insight
  • Arthritis & Rheumatology
  • Current Opinion in Rheumatology
  • bioRxiv (Cold Spring Harbor Laboratory)

Recent papers authored or co-authored by John Varga include:

  • Targeted Inhibition of Gut Microbial Trimethylamine N-Oxide Production Reduces Renal Tubulointerstitial Fibrosis and Functional Impairment in a Murine Model of Chronic Kidney Disease, 2020, Arteriosclerosis Thrombosis and Vascular Biology
  • 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases, 2024, Arthritis & Rheumatology
  • Advances in epigenetics in systemic sclerosis: molecular mechanisms and therapeutic potential, 2021, Nature Reviews Rheumatology
  • 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases, 2024, Arthritis & Rheumatology
  • Contribution of monocytes and macrophages to the pathogenesis of systemic sclerosis: recent insights and therapeutic implications, 2021, Current Opinion in Rheumatology

John Varga has been recognized as a member of the Association of American Physicians.

Best Publications

  • 2013 classification criteria for systemic sclerosis: An american college of rheumatology/European league against rheumatism collaborative initiative

    Frank Van Den Hoogen;Dinesh Khanna;Jaap Fransen;Sindhu R. Johnson

  • ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension: A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: Developed in Collaboration With the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association

    Vallerie V. McLaughlin;Stephen L. Archer;David B. Badesch;Robyn J. Barst

  • Cyclophosphamide versus placebo in scleroderma lung disease.

    Donald P. Tashkin;Robert Elashoff;Philip J. Clements;Jonathan Goldin

  • Systemic sclerosis: a prototypic multisystem fibrotic disorder.

    John Varga;David Abraham

  • ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension

    Vallerie V. McLaughlin;Stephen L. Archer;David B. Badesch;Robyn J. Barst

  • Recent developments in myofibroblast biology: paradigms for connective tissue remodeling.

    Boris Hinz;Sem H. Phan;Victor J. Thannickal;Marco Prunotto

  • Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial

    Donald P. Tashkin;Michael D. Roth;Philip J. Clements;Daniel E. Furst

  • Transforming growth factor beta (TGF beta) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts.

    J Varga;J Rosenbloom;S A Jimenez

  • Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.

    Donald P. Tashkin;Robert Elashoff;Philip J. Clements;Michael D. Roth

  • Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies.

    P. J. Clements;P. A. Lachenbruch;J. R. Seibold;B. Zee

  • Intravenous Iloprost Infusion in Patients with Raynaud Phenomenon Secondary to Systemic Sclerosis: A Multicenter, Placebo-controlled, Double-Blind Study

    Fredrick M. Wigley;Robert A. Wise;James R. Seibold;Deborah A. McCloskey

  • Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus

    Timothy R.D.J. Radstake;Olga Y Gorlova;Blanca Rueda;Jose Ezequiel Martin

  • High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: Analysis of a two-year, double-blind, randomized, controlled clinical trial

    Philip J. Clements;Daniel E. Furst;Weng Kee Wong;Maureen Mayes

  • Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities

    Swati Bhattacharyya;Jun Wei;John Varga

  • Scleroderma: from cell and molecular mechanisms to disease models.

    David J. Abraham;John Varga

  • Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: High‐dose versus low‐dose penicillamine trial

    Philip J. Clements;Eric L. Hurwitz;Weng Kee Wong;James R. Seibold

  • Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial.

    Alain H. Rook;Bruce Freundlich;Brian V. Jegasothy;Maritza I. Perez

  • Transforming growth factor beta as a therapeutic target in systemic sclerosis.

    John Varga;Boris Pasche

  • Antagonistic regulation of type I collagen gene expression by interferon-gamma and transforming growth factor-beta. Integration at the level of p300/CBP transcriptional coactivators.

    Asish K. Ghosh;Weihua Yuan;Yasuji Mori;Shu Jen Chen

  • Myofibroblasts in murine cutaneous fibrosis originate from adiponectin-positive intradermal progenitors.

    Roberta Goncalves Marangoni;Benjamin D. Korman;Jun Wei;Tammara A. Wood

Frequent Co-Authors

Sergio A. Jimenez
Sergio A. Jimenez Thomas Jefferson University
Maureen D. Mayes
Maureen D. Mayes The University of Texas at Austin
Daniel E. Furst
Daniel E. Furst University of California, Los Angeles
Virginia D. Steen
Virginia D. Steen Georgetown University
Fredrick M. Wigley
Fredrick M. Wigley Johns Hopkins University
Dinesh Khanna
Dinesh Khanna University of Michigan–Ann Arbor
Thomas A. Medsger
Thomas A. Medsger University of Pittsburgh
Richard M. Silver
Richard M. Silver Medical University of South Carolina
Philip J. Clements
Philip J. Clements University of California, Los Angeles
Christopher P. Denton
Christopher P. Denton University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative paths in the healthcare sector can offer flexibility and open new career opportunities beyond a traditional medical degree. Many students considering medicine may also be interested in graduate-level nursing, healthcare administration, or advanced nursing practice roles.

For those who wish to specialize in mental health, several institutions offer shortest post master's pmhnp online programs. These programs provide a streamlined route to becoming a Psychiatric Mental Health Nurse Practitioner.

If you are drawn to the business and management side of healthcare, pursuing a health care administration online degree could be an excellent choice. Such degrees focus on leadership, policy, and the operational aspects of healthcare organizations.

For those seeking advanced qualifications in administration, there are several cheapest mha online programs available. These affordable master’s degrees help you develop specialized management skills for healthcare settings.

Additionally, clinicians aiming for the highest practice roles can benefit from the cheapest dnp programs. A Doctor of Nursing Practice (DNP) enhances both clinical and leadership capabilities in advanced nursing.

Best Scientists Citing John Varga

Trending Scientists

Recently Published Articles